TY - JOUR AU - Chan, M. AU - Ji, S. M. AU - Yeo, Z. H. AU - Gan, L. AU - Yap, E. AU - Yap, Y. S. PY - 2012 DA - 2012// TI - Development of a next-generation sequencing method for BRCA mutation screening a comparison between a high-throughput and a benchtop platform JO - J Mol Diagn VL - 14 UR - https://doi.org/10.1016/j.jmoldx.2012.06.003 DO - 10.1016/j.jmoldx.2012.06.003 ID - Chan2012 ER - TY - STD TI - Chou LS, Liu CS-J, Boese B, Zhan X, Mao R. DNA Sequence Capture and Enrichment by Microarray Followed by Next-Generation Sequencing for Targeted Resequencing: Neurofibromatosis Type 1 Gene as a Model. Clin Chem. 2010;56(1):62–72. ID - ref2 ER - TY - JOUR AU - Leeneer, D. AU - KHellemans, J. AU - Schrivjer, J. AU - Baetens, M. AU - Poppe, B. AU - Criekinge, W. PY - 2011 DA - 2011// TI - Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations JO - Hum Mutat VL - 32 UR - https://doi.org/10.1002/humu.21428 DO - 10.1002/humu.21428 ID - Leeneer2011 ER - TY - JOUR AU - Goossens, D. AU - Moens, L. N. AU - Nelis, E. AU - Lenaerts, A. S. AU - Glassee, W. AU - Kalbe, A. PY - 2009 DA - 2009// TI - Simultaneous mutation and copy number variation (CNV) detection by multiplex PCR-based GS-FLX sequencing JO - Hum Mutat VL - 30 UR - https://doi.org/10.1002/humu.20873 DO - 10.1002/humu.20873 ID - Goossens2009 ER - TY - JOUR AU - Hernan, I. AU - Borràs, E. AU - Sousa, D. M. AU - Gamundi, M. J. AU - Mañé, B. AU - Llort, G. PY - 2012 DA - 2012// TI - Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing JO - J Mol Diagn VL - 14 UR - https://doi.org/10.1016/j.jmoldx.2012.01.013 DO - 10.1016/j.jmoldx.2012.01.013 ID - Hernan2012 ER - TY - JOUR AU - Mamanova, L. AU - Coffey, A. J. AU - Scott, C. E. AU - Kozarewa, I. AU - Turner, E. H. AU - Kumar, A. PY - 2010 DA - 2010// TI - Target-enrichment strategies for next-generation sequencing JO - Nat Methods VL - 7 UR - https://doi.org/10.1038/nmeth.1419 DO - 10.1038/nmeth.1419 ID - Mamanova2010 ER - TY - JOUR AU - Ozcelik, H. AU - Shi, X. AU - Chang, M. C. AU - Tram, E. AU - Vlasschaert, M. AU - Nicola, N. PY - 2012 DA - 2012// TI - Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer JO - J Mol Diagn VL - 14 UR - https://doi.org/10.1016/j.jmoldx.2012.03.006 DO - 10.1016/j.jmoldx.2012.03.006 ID - Ozcelik2012 ER - TY - JOUR AU - Pritchard, C. C. AU - Smith, C. AU - Salipante, S. J. AU - Lee, M. K. AU - Thornton, A. M. AU - Nord, A. S. PY - 2012 DA - 2012// TI - ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing JO - J Mol Diagn VL - 14 UR - https://doi.org/10.1016/j.jmoldx.2012.03.002 DO - 10.1016/j.jmoldx.2012.03.002 ID - Pritchard2012 ER - TY - JOUR AU - Walsh, T. AU - Lee, M. K. AU - Casadei, S. AU - Thornton, A. M. AU - Stray, S. M. AU - Pennil, C. PY - 2010 DA - 2010// TI - Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing JO - Proc Natl Acad Sci U S A VL - 107 UR - https://doi.org/10.1073/pnas.1007983107 DO - 10.1073/pnas.1007983107 ID - Walsh2010 ER - TY - JOUR AU - Walsh, T. AU - Casadei, S. AU - Lee, M. K. AU - Pennil, C. C. AU - Nord, A. S. AU - Thornton, A. M. PY - 2011 DA - 2011// TI - Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1115052108 DO - 10.1073/pnas.1115052108 ID - Walsh2011 ER - TY - JOUR AU - Rothberg, J. M. AU - Hinz, W. AU - Rearick, T. M. AU - Schultz, J. AU - Mileski, W. AU - Davey, M. PY - 2011 DA - 2011// TI - An integrated semiconductor device enabling non-optical genome sequencing JO - Nature VL - 475 UR - https://doi.org/10.1038/nature10242 DO - 10.1038/nature10242 ID - Rothberg2011 ER - TY - JOUR AU - Voelkerding, K. V. AU - Dames, S. A. AU - Durtschi, J. D. PY - 2009 DA - 2009// TI - Next-generation sequencing: from basic research to diagnostics JO - Clin Chem VL - 55 UR - https://doi.org/10.1373/clinchem.2008.112789 DO - 10.1373/clinchem.2008.112789 ID - Voelkerding2009 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2000 DA - 2000// TI - The hallmarks of cancer JO - Cell VL - 100 UR - https://doi.org/10.1016/S0092-8674(00)81683-9 DO - 10.1016/S0092-8674(00)81683-9 ID - Hanahan2000 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - MacConaill, L. E. PY - 2013 DA - 2013// TI - Existing and emerging technologies for tumor genomic profiling JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.46.5948 DO - 10.1200/JCO.2012.46.5948 ID - MacConaill2013 ER - TY - JOUR AU - Bustin, S. A. PY - 2000 DA - 2000// TI - Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays JO - J Mol Endocrinol VL - 25 UR - https://doi.org/10.1677/jme.0.0250169 DO - 10.1677/jme.0.0250169 ID - Bustin2000 ER - TY - JOUR AU - Meyerson, M. AU - Gabriel, S. AU - Getz, G. PY - 2010 DA - 2010// TI - Advances in understanding cancer genomes through second-generation sequencing JO - Nat Rev Genet VL - 11 UR - https://doi.org/10.1038/nrg2841 DO - 10.1038/nrg2841 ID - Meyerson2010 ER - TY - JOUR AU - Forbes, S. A. AU - Bindal, N. AU - Bamford, S. AU - Cole, C. AU - Kok, C. Y. AU - Beare, D. PY - 2011 DA - 2011// TI - COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer JO - Nucleic Acids Res VL - 39 UR - https://doi.org/10.1093/nar/gkq929 DO - 10.1093/nar/gkq929 ID - Forbes2011 ER - TY - STD TI - Robbins DE, Grüneberg A, Deus HF, Tanik MM, Almeida SJ. A self-updating road map of The Cancer Genome Atlas. Bioinformatics. 2013;29(10):1333–40. ID - ref19 ER - TY - JOUR AU - Chandarlapaty, S. AU - Sakr, R. A. AU - Giri, D. AU - Patil, S. AU - Heguy, A. AU - Morrow, M. PY - 2012 DA - 2012// TI - Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-1785 DO - 10.1158/1078-0432.CCR-12-1785 ID - Chandarlapaty2012 ER - TY - STD TI - Cizkova M, Cizkova M, Dujaric ME, Lehmann-Che J, Scott V, Tembo O, et al. Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab. Br J Cancer. 2013;108(9):1807–9. ID - ref21 ER - TY - STD TI - Jensen JD, Knoop A, Laenkholm AV, Grauslund M, Jensen MB, Santoni-Rugiu E, et al. PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab. Ann Oncol. 2012;23(8):2034–42. ID - ref22 ER - TY - STD TI - Bai X, Zhang E, Ye H, Nandakumar V, Wang Z, Chen L, et al. PIK3CA and TP53 gene mutations in human breast cancer tumors frequently detected by ion torrent DNA sequencing. PLoS One. 2014;9(6):e99306. ID - ref23 ER - TY - JOUR AU - Frierson, H. F. AU - Wolber, R. A. AU - Berean, K. W. AU - Franquemont, D. W. AU - Gaffey, M. J. AU - Boyd, J. C. PY - 1995 DA - 1995// TI - Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma JO - Am J Clin Pathol VL - 103 ID - Frierson1995 ER - TY - JOUR AU - Hammond, M. E. AU - Hayes, D. F. AU - Dowsett, M. AU - Allred, D. C. AU - Hagerty, K. L. AU - Badve, S. PY - 2010 DA - 2010// TI - American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer JO - Arch Pathol Lab Med VL - 134 ID - Hammond2010 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Hicks, D. G. AU - Dowsett, M. AU - McShane, L. M. AU - Allison, K. H. PY - 2014 DA - 2014// TI - Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update JO - Arch Pathol Lab Med VL - 138 UR - https://doi.org/10.5858/arpa.2013-0953-SA DO - 10.5858/arpa.2013-0953-SA ID - Wolff2014 ER - TY - STD TI - A.E. beeswarm: The bee swarm plot, an alternative to stripchart. R package version 0.1.6. 2013. http://CRAN.R-project.org/package=beeswarm. UR - http://cran.r-project.org/package=beeswarm ID - ref27 ER - TY - STD TI - R.C.T. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2014. URL http://www.R-project.org/. UR - http://www.r-project.org/ ID - ref28 ER - TY - JOUR AU - Cerami, E. AU - Gao, J. AU - Dogrusoz, U. AU - Gross, B. E. AU - Sumer, S. O. AU - Aksoy, B. A. PY - 2012 DA - 2012// TI - The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-12-0095 DO - 10.1158/2159-8290.CD-12-0095 ID - Cerami2012 ER - TY - JOUR AU - Fokkema, I. F. AU - Taschner, P. E. AU - Schaafsma, G. C. AU - Celli, J. AU - Laros, J. F. AU - Dunnen, J. T. PY - 2011 DA - 2011// TI - LOVD v. 2.0: the next generation in gene variant databases JO - Hum Mutat VL - 32 UR - https://doi.org/10.1002/humu.21438 DO - 10.1002/humu.21438 ID - Fokkema2011 ER - TY - JOUR AU - Kohlmann, A. AU - Klein, H. U. AU - Weissmann, S. AU - Bresolin, S. AU - Chaplin, T. AU - Cuppens, H. PY - 2011 DA - 2011// TI - The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories JO - Leukemia VL - 25 UR - https://doi.org/10.1038/leu.2011.155 DO - 10.1038/leu.2011.155 ID - Kohlmann2011 ER - TY - JOUR AU - Cleator, S. J. AU - Powles, T. J. AU - Dexter, T. AU - Fulford, L. AU - Mackay, A. AU - Smith, I. E. PY - 2006 DA - 2006// TI - The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis JO - Breast Cancer Res VL - 8 UR - https://doi.org/10.1186/bcr1506 DO - 10.1186/bcr1506 ID - Cleator2006 ER - TY - JOUR AU - Buttitta, F. AU - Felicioni, L. AU - Grammastro, M. AU - Filice, G. AU - Lorito, A. AU - Malatesta, S. PY - 2013 DA - 2013// TI - Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-1958 DO - 10.1158/1078-0432.CCR-12-1958 ID - Buttitta2013 ER - TY - JOUR AU - Moskalev, E. A. AU - Stöhr, R. AU - Rieker, R. AU - Hebele, S. AU - Fuchs, F. AU - Sirbu, H. PY - 2013 DA - 2013// TI - Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing JO - Virchows Arch VL - 462 UR - https://doi.org/10.1007/s00428-013-1376-6 DO - 10.1007/s00428-013-1376-6 ID - Moskalev2013 ER - TY - STD TI - Chin ELH, C da Silva, M Hegde. Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations. BMC Genet. 2013;14:14-6 ID - ref35 ER - TY - JOUR AU - Guan, Y. F. AU - Hu, H. AU - Peng, Y. AU - Gong, Y. AU - Yi, Y. AU - Shao, L. PY - 2015 DA - 2015// TI - Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing JO - Fam Cancer VL - 14 UR - https://doi.org/10.1007/s10689-014-9749-9 DO - 10.1007/s10689-014-9749-9 ID - Guan2015 ER - TY - JOUR AU - Hadd, A. G. AU - Houghton, J. AU - Choudhary, A. AU - Sah, S. AU - Chen, L. AU - Marko, A. C. PY - 2013 DA - 2013// TI - Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens JO - J Mol Diagn VL - 15 UR - https://doi.org/10.1016/j.jmoldx.2012.11.006 DO - 10.1016/j.jmoldx.2012.11.006 ID - Hadd2013 ER - TY - JOUR AU - Lin, M. T. PY - 2014 DA - 2014// TI - Mosier Sl, Thiess M, Beierel KF, Debeljak M, Tseng LH, et al. Clinical Validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing JO - Am J Clin Pathol VL - 141 UR - https://doi.org/10.1309/AJCPMWGWGO34EGOD DO - 10.1309/AJCPMWGWGO34EGOD ID - Lin2014 ER - TY - JOUR AU - Nijman, I. J. AU - Montfrans, J. M. AU - Hoogstraat, M. AU - Boes, M. L. AU - Corput, L. AU - Renner, E. D. PY - 2014 DA - 2014// TI - Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies JO - J Allergy Clin Immunol VL - 133 UR - https://doi.org/10.1016/j.jaci.2013.08.032 DO - 10.1016/j.jaci.2013.08.032 ID - Nijman2014 ER - TY - STD TI - Barbareschi M, Buttitta F, Felicioni L, Cotrupi S, Barassi F, Del Grammastro M, et al. Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. Clin Cancer Res. 2007;13(20):6064–9. ID - ref40 ER - TY - STD TI - Lai YL, Mau BL, Cheng WH, Chen HM, Chiu HH, Tzen CY. et al. PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients. Ann Surg Oncol. 2008;15(4):1064–9. ID - ref41 ER - TY - JOUR AU - Li, S. Y. AU - Rong, M. AU - Grieu, F. AU - Iacopetta, B. PY - 2006 DA - 2006// TI - PIK3CA mutations in breast cancer are associated with poor outcome JO - Breast Cancer Res Treat VL - 96 UR - https://doi.org/10.1007/s10549-005-9048-0 DO - 10.1007/s10549-005-9048-0 ID - Li2006 ER - TY - STD TI - Mangone FR, Bobrovnitchaia IG, Salaorni S, Manuli E, Nagai MA.PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients. Clinics (Sao Paulo). 2012;67(11):1285–90. ID - ref43 ER - TY - STD TI - Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res. 2005;65(7):2554–9. ID - ref44 ER - TY - JOUR AU - Koboldt, D. C. AU - Fulton, R. S. AU - McLellan, M. D. AU - Schmidt, H. AU - Kalicki-Veizer, J. AU - McMichael, J. F. PY - 2012 DA - 2012// TI - Comprehensive molecular portraits of human breast tumours JO - Nature VL - 490 UR - https://doi.org/10.1038/nature11412 DO - 10.1038/nature11412 ID - Koboldt2012 ER - TY - JOUR AU - Rohlin, A. AU - Wernersson, J. AU - Engwall, Y. AU - Wiklund, L. AU - Bjoerk, J. AU - Nordling, M. PY - 2009 DA - 2009// TI - Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques JO - Hum Mutat VL - 30 UR - https://doi.org/10.1002/humu.20980 DO - 10.1002/humu.20980 ID - Rohlin2009 ER - TY - JOUR AU - Walsh, T. AU - Casadei, S. AU - Coats, K. H. AU - Swisher, E. AU - Stray, S. M. AU - Higgins, J. PY - 2006 DA - 2006// TI - Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer JO - JAMA VL - 295 UR - https://doi.org/10.1001/jama.295.12.1379 DO - 10.1001/jama.295.12.1379 ID - Walsh2006 ER - TY - STD TI - Arsenic R, Lehmann A, Budczies J, Koch I, Prinzler J, Kleine-Tebbe A, et al. Analysis of PIK3CA mutations in breast cancer subtypes. Appl Immunohistochem Mol Morphol. 2014;22(1):50–6. ID - ref48 ER - TY - STD TI - Ikenoue T, Kanai F, Hikiba Y, Obata T, Tanaka Y, Imamura J, et al. Functional analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res. 2005;65(11):4562–7. ID - ref49 ER - TY - JOUR AU - Gymnopoulos, M. AU - Elsliger, M. A. AU - Vogt, P. K. PY - 2007 DA - 2007// TI - Rare cancer-specific mutations in PIK3CA show gain of function JO - Proc Natl Acad Sci U S A VL - 104 UR - https://doi.org/10.1073/pnas.0701005104 DO - 10.1073/pnas.0701005104 ID - Gymnopoulos2007 ER - TY - JOUR AU - Boyault, S. AU - Drouet, Y. AU - Navarro, C. AU - Bachelot, T. AU - Lasset, C. AU - Treilleux, I. PY - 2012 DA - 2012// TI - Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes JO - Breast Cancer Res Treat VL - 132 UR - https://doi.org/10.1007/s10549-011-1518-y DO - 10.1007/s10549-011-1518-y ID - Boyault2012 ER - TY - STD TI - Kalinsky K, Jacks LM, Heguy A, Patil S, Drobnjak M, Bhanot UK, et al. PIK3CA mutation associates with improved outcome in breast cancer. Clin Cancer Res. 2009;15(16):5049–59. ID - ref52 ER - TY - JOUR AU - Dunlap, J. AU - Le, C. AU - Shukla, A. AU - Patterson, J. AU - Presnell, A. AU - Heinrich, M. C. PY - 2010 DA - 2010// TI - Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma JO - Breast Cancer Res Treat VL - 120 UR - https://doi.org/10.1007/s10549-009-0406-1 DO - 10.1007/s10549-009-0406-1 ID - Dunlap2010 ER - TY - JOUR AU - Hutter, R. V. PY - 1984 DA - 1984// TI - Pathological parameters useful in predicting prognosis for patients with breast cancer JO - Monogr Pathol VL - 25 ID - Hutter1984 ER - TY - STD TI - McGuire WL, Clark, GM, Dressler LG and Owens, MA. Role of steroid hormone receptors as prognostic factors in primary breast cancer. NCI Monogr. 1986;1:19–23. ID - ref55 ER - TY - STD TI - Huang YE, Iijima M, Parent CA, Funamoto S, Firtel RA,Devreotes P, et al. Receptor-mediated regulation of PI3Ks confines PI(3,4,5)P3 to the leading edge of chemotaxing cells. Mol Biol Cell. 2003;14(5):1913–22. ID - ref56 ER - TY - STD TI - Cizkova M, Susini A, Vacher S,  Cizeron-Clairac G, Andrieu C, Driouch K, et al. PIK3CA mutation impact on survival in breast cancer patients and in ER alpha, PR and ERBB2-based subgroups. Breast Cancer Res. 2012;14(1):R28. ID - ref57 ER - TY - JOUR AU - Baselga, J. AU - Cortés, J. AU - Im, S. A. AU - Clark, E. AU - Ross, G. AU - Kiermaier, A. PY - 2014 DA - 2014// TI - Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.54.5384 DO - 10.1200/JCO.2013.54.5384 ID - Baselga2014 ER - TY - JOUR AU - Joensuu, H. AU - Kellokumpu-Lehtinen, P. L. AU - Bono, P. AU - Alanko, T. AU - Kataja, V. AU - Asola, R. PY - 2006 DA - 2006// TI - Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer JO - N Engl J Med VL - 354 UR - https://doi.org/10.1056/NEJMoa053028 DO - 10.1056/NEJMoa053028 ID - Joensuu2006 ER - TY - JOUR AU - Loi, S. AU - Michiels, S. AU - Lambrechts, D. AU - Fumagalli, D. AU - Claes, B. AU - Kellokumpu-Lehtinen, P. L. PY - 2013 DA - 2013// TI - Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancer JO - J Natl Cancer Inst VL - 105 UR - https://doi.org/10.1093/jnci/djt121 DO - 10.1093/jnci/djt121 ID - Loi2013 ER - TY - JOUR AU - Fu, X. AU - Osborne, C. K. AU - Schiff, R. PY - 2013 DA - 2013// TI - Biology and therapeutic potential of PI3K signaling in ER+/HER2-negative breast cancer JO - Breast VL - 22 UR - https://doi.org/10.1016/j.breast.2013.08.001 DO - 10.1016/j.breast.2013.08.001 ID - Fu2013 ER - TY - JOUR AU - Harle, A. AU - Lion, M. AU - Lozano, N. AU - Merlin, J. L. PY - 2013 DA - 2013// TI - Clinical, diagnostic significance and theranostic interest of PIK3CA gene mutations in breast cancer JO - Bull Cancer VL - 100 ID - Harle2013 ER -